Status:
COMPLETED
Liposomal Bupivacaine vs Dexamethasone ISB
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Shoulder Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
In this study, patients receiving shoulder arthroscopy will receive an interscalene block for pain management containing either liposomal bupivacaine and standard bupivacaine or standard bupivacaine a...
Eligibility Criteria
Inclusion
- ASA I-III
- Age 18 years or older
- Scheduled for elective outpatient arthroscopic shoulder surgery
Exclusion
- History of allergy to local anesthetic, or one of the study medications
- Pre-existing neurological deficits
- Psychiatric or cognitive disorders that prohibit patients from following study protocol
- History of drug or alcohol abuse
- Chronic opioid use (longer than 3 months)
- Chronic pain syndromes
- Infection at the site of injection
- Patients with severe pulmonary disease
- Herniated cervical disc, cervical myelopathy
- Contraindication for general anesthesia and/or interscalene nerve block
- Pregnancy
- Open shoulder arthrotomies.
- Non English speakers
Key Trial Info
Start Date :
July 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 19 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04047446
Start Date
July 11 2019
End Date
March 19 2021
Last Update
August 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021